Article

Age-stratified seroprevalence of antibodies against SARS-CoV-2 in the pre- and post-vaccination era, February 2020–March 2022, Japan

2022-07-12

Abstract excerpt

Japan has reported a small number of COVID-19 cases relative to other countries. Because not all infected people receive diagnostic tests for COVID-19, the reported number of COVID-19 cases must be lower than the actual number of infections. Assessments of the presence of antibodies against the spike protein of SARS-CoV-2 can retrospectively determine the history of natural infection and vaccination. In this study...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b3b14e84-7434-57ca-b20d-ac71bb0c3ee5
DOI: 10.1101/2022.07.11.22277481

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Age-stratified seroprevalence of antibodies against SARS-CoV-2 in the pre- and post-vaccination era, February 2020–March 2022, JapanDOI 10.1101/2022.07.11.22277481Read

SARS-CoV-2-Specific Immune Responses in Vaccination and Infection during the Pandemic in 2020–2022Semantic proximity Read

Seroprevalence of SARS-CoV-2 antibodies prior to the widespread introduction of vaccine programmes in the WHO European Region, January - December 2020: a systematic reviewSemantic proximity Read

Global seroprevalence of SARS-CoV-2 antibodies: a systematic review and meta-analysisSemantic proximity Read

Seroincidence of SARS-CoV-2 infection prior to and during the rollout of vaccines in a community-based prospective cohort of U.S. adultsSemantic proximity Read

Demographic and Clinical Factors Associated With Anti–SARS-CoV-2 Antibody Levels After 2 BNT162b2 mRNA Vaccine DosesSemantic proximity Read

National- and state-level SARS-CoV-2 immunity trends from January 2020 to December 2023: a mathematical modeling analysisSemantic proximity Read

Global SARS-CoV-2 seroprevalence: a systematic review and meta-analysis of standardized population-based studies from Jan 2020-May 2022Semantic proximity Read

Estimated SARS-CoV-2 Antibody Seroprevalence and Infection to Case Ratio Trends in 50 States and District of Columbia, United States—October 25, 2020, to February 26, 2022Semantic proximity Read

SARS-CoV-2 Seroprevalence Studies: A Rapid ReviewSemantic proximity Read

The Impact of SARS-CoV-2 Vaccination and Infection on Neutralising Antibodies: A Nation-Wide Cross-Sectional AnalysisSemantic proximity Read

Prevalence of SARS-CoV-2 antibodies and associated factors in the adult population of Belgium: a general population cohort study between March 2021 and April 2022Semantic proximity Read

Increased SARS-CoV-2 Seroprevalence and the Spread of Cases of Infection Without Awareness Among Healthcare Workers Through 2020-2022 in a Japanese Medical CenterSemantic proximity Read